Our testing gives you both flexibility and reliability. Labcorp offers dedicated HIV client services and a national infrastructure of more than 2,000 patient service centers. Connectivity solutions range from easy-to-use web based applications to sophisticated integrations that allow efficient and effective communication.
We offer the latest CDC-recommended PrEP baseline and monitoring panels for oral and injectable PrEP, helping you minimize unnecessary out-of-pocket costs so you can focus on what matters most: your patients.
The Centers for Disease Control (CDC) recommends HIV testing for all individuals between ages 13 and 64 at least once as part of standard health care.
Annual screening is recommended for those persons with known or reported risk factors. All pregnant persons should be tested for HIV.
Test options include HIV testing options include:
The Department of Health and Human Services (DHHS) Guidelines recommend genotypic testing at baseline and at first and second treatment failures in patients with suboptimal response or virologic failure.¹
Testing options include:
Labcorp provides genotypic and phenotypic testing for treatment experienced patients. Labcorp is the only laboratory offering phenotypic testing and combined genotypic-phenotypic testing to determine ARV susceptibility for complex patient scenarios.
Testing options include:
Genotypic testing interrogating the viral archive along with tropism testing of the DNA compartment provide data to support treatment changes without treatment interruption.
Testing options include:
We offer the latest CDC-recommended PrEP baseline and monitoring panels for oral and injectable PrEP, helping you minimize unnecessary out-of-pocket costs so you can focus on what matters most: your patients.
The Centers for Disease Control (CDC) recommends HIV testing for all individuals between ages 13 and 64 at least once as part of standard health care.
Annual screening is recommended for those persons with known or reported risk factors. All pregnant persons should be tested for HIV.
Test options include HIV testing options include:
The Department of Health and Human Services (DHHS) Guidelines recommend genotypic testing at baseline and at first and second treatment failures in patients with suboptimal response or virologic failure.¹
Testing options include:
Labcorp provides genotypic and phenotypic testing for treatment experienced patients. Labcorp is the only laboratory offering phenotypic testing and combined genotypic-phenotypic testing to determine ARV susceptibility for complex patient scenarios.
Testing options include:
Genotypic testing interrogating the viral archive along with tropism testing of the DNA compartment provide data to support treatment changes without treatment interruption.
Testing options include:
